SPL 4.40% 9.5¢ starpharma holdings limited

Question, page-8

  1. 12,872 Posts.
    lightbulb Created with Sketch. 1420
    "Starpharma said it would like to manufacture Viraleze in Australia".

    The above statement was expressed in an article previously posted

    Did not realise tga is currently allowing expedited assessment processing for medical devices associated with COVID-19

    Viraleze™ fits into this category


    Therapeutic Goods Administration (TGA)
    Australian Government Department of Health


    2 October 2020
    The Therapeutic Goods Administration (TGA) is currently undertaking an expedited assessment process for all medical devices associated with the detection, prevention and treatment of COVID-19. We are committed to supporting suppliers with the Australian requirements and encourage potential suppliers to submit an application for inclusion on the Australian Register of Therapeutic Goods (ARTG). Sponsors are not required to request or submit a priority review as all applications in relation to COVID-19 tests are already being expedited as a matter of priority in assessment queues.






      • Category:Medical devices/IVDs
    Last edited by antibotter: 08/02/21
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $39.17M
Open High Low Value Volume
9.2¢ 9.6¢ 9.2¢ $81.30K 864.2K

Buyers (Bids)

No. Vol. Price($)
1 28056 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1285 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.